Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait Fulltext Access 10 Pages 2006
Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions Fulltext Access 10 Pages 2006
Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge Fulltext Access 10 Pages 2006
The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: A new repertoire evolves over 12 months Fulltext Access 10 Pages 2006
Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65 Fulltext Access 10 Pages 2006
Mycobacterial 70 kD heat-shock protein is an effective subunit vaccine against bovine paratuberculosis Fulltext Access 10 Pages 2006
Vaccine potential of recombinant Ornithobacterium rhinotracheale antigens Fulltext Access 10 Pages 2006
Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model Fulltext Access 10 Pages 2006
Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria–tetanus–pertussis vaccine (DTP-Hib), in Indonesian infants Fulltext Access 10 Pages 2006
Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma Fulltext Access 10 Pages 2006
Vaccination of chicken embryos with escape mutants of La Sota Newcastle disease virus induces a protective immune response Fulltext Access 10 Pages 2006
Leishmania donovani: Identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis Fulltext Access 10 Pages 2006
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS Fulltext Access 10 Pages 2006
Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance Fulltext Access 10 Pages 2006
Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice Fulltext Access 10 Pages 2006
Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa Fulltext Access 10 Pages 2006
Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study Fulltext Access 10 Pages 2006
Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies Fulltext Access 10 Pages 2006
Presentation of the HCV-derived lipopeptide LP20–44 by dendritic cells enhances function of in vitro-generated CD4+ T cells via up-regulation of TLR2 Fulltext Access 10 Pages 2006
Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion Fulltext Access 10 Pages 2006
Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine Fulltext Access 10 Pages 2006
A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy Fulltext Access 10 Pages 2006
Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge Fulltext Access 10 Pages 2006
Evaluation of adenyl cyclase toxin constructs from Bordetella pertussis as candidate vaccine components in an in vitro model of complement-dependent intraphagocytic killing Fulltext Access 10 Pages 2006
Environmental exposure to residential pesticides, chemicals, dusts, fumes, and metals, and risk of childhood germ cell tumors Fulltext Access 10 Pages 2006
Urban dust fecal pollution in Mexico City: Antibiotic resistance and virulence factors of Escherichia coli Fulltext Access 10 Pages 2006
Rural drinking water at supply and household levels: Quality and management Fulltext Access 10 Pages 2006
Effects of winter air pollution on pulmonary function of school children in Shenyang, China Fulltext Access 10 Pages 2006
Comparison of different biological methods for the assessment of ecotoxicological risks Fulltext Access 10 Pages 2006
Lead exposure and birth outcomes in five communities in Shoshone County, Idaho Fulltext Access 10 Pages 2006
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo Fulltext Access 10 Pages 2006
IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice Fulltext Access 10 Pages 2006
Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load? Fulltext Access 10 Pages 2006
Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells Fulltext Access 10 Pages 2006
Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro Fulltext Access 10 Pages 2006
Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs Fulltext Access 10 Pages 2006
Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry Fulltext Access 10 Pages 2006
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection Fulltext Access 10 Pages 2006
Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits Fulltext Access 10 Pages 2006
Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs) Fulltext Access 10 Pages 2006
Booster immunization of antigen primed mice with anti-idiotypic T cells generates antigen-specific memory T cell response Fulltext Access 10 Pages 2006
Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development Fulltext Access 10 Pages 2006
Quantitative evaluation of genetic and environmental parameters determining antibody response induced by vaccination against bovine respiratory syncytial virus Fulltext Access 10 Pages 2006
DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus Fulltext Access 10 Pages 2006
Willingness to be vaccinated against shigella and other forms of dysentery: A comparison of three regions in Asia Fulltext Access 10 Pages 2006
Molecular characterization of attenuated Japanese encephalitis live vaccine strain ML-17 Fulltext Access 10 Pages 2006
Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1) Fulltext Access 10 Pages 2006
Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum Fulltext Access 10 Pages 2006
A nematode allergen elicits protection against challenge infection under specific conditions Fulltext Access 10 Pages 2006
HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant Fulltext Access 10 Pages 2006
Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates Fulltext Access 10 Pages 2006
Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus Fulltext Access 10 Pages 2006
Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice Fulltext Access 10 Pages 2006
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine Fulltext Access 10 Pages 2006
Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy Fulltext Access 10 Pages 2006
Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A Fulltext Access 10 Pages 2006
Establishment of a non-human primate Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine formulations Fulltext Access 10 Pages 2006
Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers Fulltext Access 10 Pages 2006
Novel surface polypeptides of Campylobacter jejuni as traveller's diarrhoea vaccine candidates discovered by proteomics Fulltext Access 10 Pages 2006
TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models Fulltext Access 10 Pages 2006
Vaccinating healthcare workers against influenza to protect the vulnerable—Is it a good use of healthcare resources?: A systematic review of the evidence and an economic evaluation Fulltext Access 10 Pages 2006
Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV Fulltext Access 10 Pages 2006
Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model Fulltext Access 10 Pages 2006
Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK Fulltext Access 10 Pages 2006
The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection Fulltext Access 10 Pages 2006
Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life Fulltext Access 10 Pages 2006
Management of cardiovascular risk factors in people with diabetes in primary care: Cross-sectional study Fulltext Access 10 Pages 2006
Economic evaluation of varicella vaccination in Spain—Results from a dynamic model Fulltext Access 10 Pages 2006
Optimisation of the inactivated vaccine dose against heartwater and in vitro quantification of Ehrlichia ruminantium challenge material Fulltext Access 10 Pages 2006
Community cohort study of rotavirus and other enteropathogens: Are routine vaccinations associated with sex-differential incidence rates? Fulltext Access 10 Pages 2006
Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants Fulltext Access 10 Pages 2006
Protective immunity and lack of histopathological damage two years after DNA vaccination against infectious hematopoietic necrosis virus in trout Fulltext Access 10 Pages 2006
Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen Fulltext Access 10 Pages 2006
Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves Fulltext Access 10 Pages 2006
Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine Fulltext Access 10 Pages 2006
Influenza vaccination among cardiovascular disease sufferers in Spain: Related factors and trend, 1993–2003 Fulltext Access 10 Pages 2006
Transcutaneous immunization with inactivated influenza virus induces protective immune responses Fulltext Access 10 Pages 2006
A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses Fulltext Access 10 Pages 2006
The MHC-haplotype influences primary, but not memory, immune responses to an immunodominant peptide containing T- and B-cell epitopes of the caprine arthritis encephalitis virus Gag protein Fulltext Access 10 Pages 2006
Immune response to influenza vaccination in community-dwelling Chinese elderly persons Fulltext Access 10 Pages 2006
Correlation between national income, HIV/AIDS and political status and mortalities in African countries Fulltext Access 10 Pages 2006
DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy Fulltext Access 10 Pages 2006
Comparative immune responses in Japanese flounder, Paralichthys olivaceus after vaccination with viral hemorrhagic septicemia virus (VHSV) recombinant glycoprotein and DNA vaccine using a microarray analysis Fulltext Access 10 Pages 2006
Could a single dose of pneumococcal conjugate vaccine in children be effective? : Modeling the optimal age of vaccination Fulltext Access 10 Pages 2006
Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70 Fulltext Access 10 Pages 2006
The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles Fulltext Access 10 Pages 2006
A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines Fulltext Access 10 Pages 2006
Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses Fulltext Access 10 Pages 2006
Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine Fulltext Access 10 Pages 2006
Genetic stability of live, cold-adapted influenza virus components of the FluMist®/CAIV-T vaccine throughout the manufacturing process Fulltext Access 10 Pages 2006
A novel strategy to compensate the disadvantages of live vaccine using suicide-gene system and provide better antitumor immunity Fulltext Access 10 Pages 2006
Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG Fulltext Access 10 Pages 2006